Age-related diseases

There are 1,028 papers on age-related diseases in aging research: 2 trials and 95 observational studies in people, 35 in animals, 3 in cells, 848 reviews. The newest story, Nov 14, 2026: “Blood protein scores linked to future age-related disease”.

Disease

1,028 papers study it4,742 more mention it423 findings

95 new papers in 30 daysSee all 5,770 papers on age-related diseases

At a glance

Social disadvantage, obesity and several biological age measures are associated with age-related diseases in human studies. A plasma protein panel predicts disease, while studies report no clear links for intrinsic epigenetic age acceleration or, among Chinese oldest-old adults in Hong Kong, telomere length. Reviews link these diseases with cellular senescence, mitochondrial dysfunction and impaired autophagy.

423 findings in 410 papers from 1975 to 2026, 31 of them since April 2026

“the association between IGF-1 and risk is generally U-shaped, indicating that both high and low levels of IGF-1 may be detrimental”
The antagonistic pleiotropy of insulin-like growth factor 1Aging cell2021doi:10.1111/acel.13443
  • Human trial2
  • Humans95
  • Animals27
  • Model organisms8
  • Cells3
  • In silico39

Interventions

43

Caloric restriction

downin reviews3downin humans1downin monkeys1

5 studies
  1. Caloric restriction protects against age-related diseases (preclinical studies).

    “polyphenols, caloric restriction, and exercise (lifestyle interventions), show an effective role in the treatment of several disorders related to ageing”

    Reviewpreclinical studies

    Autophagy decline during ageing: Molecular regulation, tissue specificity, and therapeutic potential

    Pathology, research and practice

  2. Caloric restriction decreases age-related diseases in monkeys (Compared with monkeys fed a normal intake).

    “monkeys fed a reduced-calorie diet lived longer and had fewer age-related diseases than monkeys fed a normal intake.”

    ReviewCompared with monkeys fed a normal intake

    A healthy lifestyle in a pill

    C&EN Global Enterprise

  3. Caloric restriction prevents age-related diseases in humans.

    “Preventive effects of DR on age-related diseases have also been reported in human.”

    Review

    Longevity through diet restriction and immunity

    BMB reports

  4. Caloric restriction decreases age-related diseases.

    “CR can also have different beneficial effects on improving lifespan and decreasing the age-associated diseases”

    Review

    Calorie Restriction-Regulated Molecular Pathways and Its Impact on Various Age Groups: An Overview

    DNA and cell biology

  5. Caloric restriction decreases age-related diseases.

    “CR and CRM drugs have shown to decrease age-related diseases and can act as an anti-cancer agent.”

    Review

    Mass spectrometric investigations of caloric restriction mimetics

    Proteomics

More on Caloric restriction

Rapamycin

downin reviews3downin humans1

4 studies
  1. Rapamycin prevents age-related diseases.

    “has been repeatedly demonstrated to extend lifespan and prevent or delay several age-related diseases in diverse model systems”

    Review

    Testing the Translational Potential of Rapamycin on Healthy Aging

    GSA 2025 abstract

  2. Rapamycin prevents age-related diseases.

    “has been repeatedly demonstrated to extend lifespan and prevent or delay age-related diseases in diverse model systems”

    Review

    Blazing a trail for the clinical use of rapamycin as a geroprotecTOR

    GeroScience

  3. Rapamycin decreases age-related diseases.

    “inhibition of mTOR through treatment with rapamycin reproducibly delays ageing and disease through specific inhibition of the mTOR complexes”

    Review

    Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease

    Sub-cellular biochemistry

  4. Rapamycin decreases age-related diseases in otherwise healthy elderly people; reported as initial clinical data.

    “geroprotective compounds such as rapamycin and metformin may be effective at delaying or reversing age-related disease”

    Reviewin otherwise healthy elderly people; reported as initial clinical data

    Translational geroscience: A new paradigm for 21st century medicine

    Translational medicine of aging

More on Rapamycin

Senolytics

downin reviews4

4 studies
  1. Senolytics decrease age-related diseases.

    “selectively killing SCs improves age-related disorders”

    Review

    Recent Advancement in Elimination Strategies and Potential Rejuvenation Targets of Senescence

    Advanced biology

  2. Senolytics protect against age-related diseases (preclinical models).

    “senolytic drugs that selectively induce senescent cell removal, have been shown to delay, prevent, alleviate, or treat multiple age-associated diseases in preclinical models”

    Reviewpreclinical models

    Senescent Cells: A Therapeutic Target in Cardiovascular Diseases

    Cells

  3. Senolytics prevent age-related diseases (animal models).

    “Some senolytics and senomorphics have been proven to markedly prevent or treat ARDs in animal models.”

    Reviewanimal models

    Senotherapeutics: emerging strategy for healthy aging and age-related disease

    BMB reports

  4. Senolytics decrease age-related diseases.

    “clearance of senescent cells has shown to attenuate aspects of age-related disorders”

    Review

    Adipose tissue inflammation in aging

    Experimental gerontology

More on Senolytics

Mesenchymal stem cell-derived exosomes

downin reviews3

3 studies
  1. Mesenchymal stem cell-derived exosomes decrease age-related diseases.

    “summarizes the current research status of MSCs-Exos in mitigating aging and age-related diseases”

    Review

    Advancements in Research on Mesenchymal Stem-Cell-Derived Exosomal miRNAs: A Pivotal Insight into Aging and Age-Related Diseases

    Biomolecules

  2. Mesenchymal stem cell-derived exosomes decrease age-related diseases in age-related diseases.

    “MSCs and their exosomes can treat age-related diseases through mechanisms such as oxidative stress (OS), Wnt/β-catenin signaling pathway, mitogen-activated protein kinases (MAPK) signaling pathway”

    Reviewin age-related diseases

    Mechanism of mesenchymal stem cells and exosomes in the treatment of age-related diseases

    Frontiers in immunology

  3. Mesenchymal stem cell-derived exosomes decrease age-related diseases.

    “MSCs-Exo can improve ageing and age-related diseases”

    Review

    Ageing and mesenchymal stem cells derived exosomes: Molecular insight and challenges

    Cell biochemistry and function

More on Mesenchymal stem cell-derived exosomes

Metformin

downin humans2downin reviews1

3 studies
  1. Metformin protects against age-related diseases.

    “Metformin has been shown to significantly delay the onset of age-related diseases and increase lifespan in several model organisms.”

    Review

    Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease

    Aging and disease

  2. Metformin decreases age-related diseases in otherwise healthy elderly people; reported as initial clinical data.

    “geroprotective compounds such as rapamycin and metformin may be effective at delaying or reversing age-related disease”

    Reviewin otherwise healthy elderly people; reported as initial clinical data

    Translational geroscience: A new paradigm for 21st century medicine

    Translational medicine of aging

  3. Metformin protects against age-related diseases in humans.

    “Metformin, which has demonstrated protective effects against several age-related diseases in humans”

    Review

    Metformin as a Tool to Target Aging

    Cell metabolism

More on Metformin

Mesenchymal stem cells

downin reviews2

2 studies
  1. Mesenchymal stem cells decrease age-related diseases.

    “can improve the symptoms and prognosis of aging-related diseases and potentially slow the aging process through multiple pathways”

    Review

    Advances in mesenchymal stem cell and exosome-based therapies for aging and age-related diseases

    Stem cell research & therapy

  2. Mesenchymal stem cells decrease age-related diseases in age-related diseases.

    “MSCs exert curative effects on a variety of age-related diseases through regeneration and repair of aging cells and organs”

    Reviewin age-related diseases

    Mechanism of mesenchymal stem cells and exosomes in the treatment of age-related diseases

    Frontiers in immunology

More on Mesenchymal stem cells

Senotherapeutics

downin reviews2

2 studies
  1. Senotherapeutics decrease age-related diseases.

    “Senotherapeutics comprising senolytics and senostats/senomorphs of natural and synthetic origin are powerful pharmacological interventions to combat aging and age-related disorders (ARD)”

    Review

    Next-gen senotherapeutics: AI/ML-driven strategies for aging and age-related disorders

    Advances in pharmacology (San Diego, Calif.)

  2. Senotherapeutics protect against age-related diseases.

    “Killing of senescent cells and/or ameliorate their SASP-related negative effects are currently considered to be effective mitochondria-directed gerotherapeutic approaches for fighting against age-related disorders.”

    Review

    Mitochondria-targeted senotherapeutic interventions

    Biogerontology

More on Senotherapeutics

Nicotinamide mononucleotide

downin M. organisms1downin reviews1

2 studies
  1. Nicotinamide mononucleotide decreases age-related diseases.

    “NMN significantly improves recovery from aging-related diseases, such as diminished heart function, reduced fertility, memory decline, and diabetes.”

    Review

    Research progress on anti-aging effects of β-nicotinamide mononucleotide (NMN)

    Sheng li xue bao : [Acta physiologica Sinica]

  2. Nicotinamide mononucleotide decreases age-related diseases in M. organisms (ingestion, as reported in cited model-organism work).

    “In model organisms, ingestion of NMN has been shown to improve age-related diseases and probably delay death.”

    Reviewingestion, as reported in cited model-organism work

    Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging

    Aging and disease

More on Nicotinamide mononucleotide

Polyphenols

downin reviews2

2 studies
  1. Polyphenols prevent age-related diseases.

    “Polyphenols can prevent age-related diseases because they regulate complex networks of cellular processes such as oxidative damage, inflammation, cellular aging, and autophagy”

    Reviewvia regulation of cellular processes including oxidative damage, inflammation, cellular aging and autophagy

    Targeting AMPK signaling by polyphenols: a novel strategy for tackling aging

    Food & function

  2. Polyphenols protect against age-related diseases.

    “some of them have been proposed as senolytic agents to protect against age-related disorders, such as cancer, cardiovascular and neurodegenerative diseases”

    Review

    Mechanisms of aging and potential role of selected polyphenols in extending healthspan

    Biochemical pharmacology

More on Polyphenols

Rosmarinus officinalis

downin reviews1

1 study
  1. Rosmarinus officinalis protects against age-related diseases.

    “beneficial effects against neurological, metabolic, and age-related disorders”

    Review

    Rosemary bioactive phytochemicals as a strategy for the management of age related conditions

    Discover Food

More on Rosmarinus officinalis

All 43

Effects

4

Box-counting fractal dimension

downin humans1

1 study
  1. Age-related diseases are linked with lower box-counting fractal dimension in participants with age-related diseases compared to healthy (2.1 times faster (p = 0.047)).

    “Decreased box-counting fractal dimension was present in old patients, and this decrease was 2.1 times faster in participants who had age-related diseases (p = 0.047).”

    Humansin participants with age-related diseases compared to healthyretina

    Retinal microvascular complexity as a putative biomarker of biological age: a pilot study

    Biogerontology

More on Box-counting fractal dimension

Hydrogen sulfide

downin humans1

1 study
  1. Age-related diseases decrease hydrogen sulfide in humans (SMD: -1.25; 95% CI: -1.98; -0.52).

    “The circulating levels of H2S were significantly reduced in patients with progressive, chronic, and degenerative diseases compared with healthy people”

    Reviewin patients with progressive, chronic, and degenerative diseases compared with healthy people

    Circulating Levels of Hydrogen Sulfide (H₂S) in Patients with Age-Related Diseases: A Systematic Review and Meta-Analysis

    Biomolecules

More on Hydrogen sulfide

Healthspan

downin reviews1

1 study
  1. Age-related diseases impair healthspan.

    “reduce the impact of age-associated diseases as a way of extending the human healthspan”

    Review

    Metabolic Biomarkers in Aging and Anti-Aging Research

    Advances in experimental medicine and biology

Lifespan

downin humans1

1 study
  1. Age-related diseases shorten lifespan in humans.

    “Here we discuss the role of nucleoporins in a diverse set of diseases, many of which directly or indirectly increase in occurrence and severity as we age, and often shorten the human lifespan.”

    Review

    The roles of the nuclear pore complex in cellular dysfunction, aging and disease

    Seminars in cell & developmental biology

Upstream

30

Cellular senescence

upin reviews8

8 studies
  1. Cellular senescence increases age-related diseases (persistent senescence).

    “driving inflammation, fibrosis, and age-related disease when persistent”

    Reviewpersistent senescence

    Killing wisely: precision senolytics in the age of frailty

    Genes & development

  2. Cellular senescence increases age-related diseases.

    “cellular senescence is identified as the core driving mechanism”

    Review

    Targeting Cellular Senescence: Pathophysiology in Multisystem Age-Related Diseases

    Biomedicines

  3. Cellular senescence increases age-related diseases.

    “The demonstration in model organisms that cellular senescence drives aging and age-related diseases”

    Review

    Recent advances in the discovery of senolytics

    Mechanisms of ageing and development

  4. Cellular senescence increases age-related diseases within a feed-forward loop with immunosuppression.

    “It seems that cellular senescence and immunosuppression establish a feed-forward process which promotes the aging process and age-related diseases.”

    Reviewwithin a feed-forward loop with immunosuppression

    Feed-forward regulation between cellular senescence and immunosuppression promotes the aging process and age-related diseases

    Ageing research reviews

  5. Cellular senescence increases age-related diseases.

    “it plays a detrimental role in a large array of age-related pathologies”

    Review

    Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

  6. Cellular senescence increases age-related diseases.

    “Cellular senescence and the associated secretory phenotype (SASP) promote disease in the aged population.”

    Review

    Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms

    Carcinogenesis

  7. Cellular senescence induces age-related diseases.

    “we highlight the evidence that cellular senescence has a causative role in multiple diseases associated with ageing”

    Review

    The role of cellular senescence in ageing and endocrine disease

    Nature reviews. Endocrinology

  8. Cellular senescence induces age-related diseases.

    “Accumulation of cellular senescence has a casual role in aging-related disease”

    Review

    Time for the systems-level integration of aging: Resilience enhancing strategies to prevent Alzheimer's disease

    Progress in neurobiology

More on Cellular senescence

FOXO3

mediatesin humans1downin reviews1

2 studies
  1. FOXO3 decreases age-related diseases.

    “changes in the levels and post-translational modifications of FOXO3 protein can maintain organismal homeostasis and improve age-related diseases”

    Review

    The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts

    Life sciences

  2. FOXO3 mediates age-related diseases in humans.

    “plays a regulatory role in longevity and in age-related diseases”

    Review

    FoxO3 Regulates the Progress and Development of Aging and Aging-Related Diseases

    Current molecular medicine

More on FOXO3

CXC chemokines

mediatesin reviews1

1 study
  1. CXC chemokines mediate age-related diseases.

    “CXC chemokines, as critical components of SASP, have been demonstrated to play important roles in various age-related diseases and cancers.”

    Review

    The relationship between CXC chemokines and cellular senescence: from mechanisms to therapy

    Biogerontology

More on CXC chemokines

Clonal hematopoiesis of indeterminate potential

mediatesin humans1

1 study
  1. Clonal hematopoiesis of indeterminate potential mediates age-related diseases in humans.

    “Clonal hematopoiesis (CH) has emerged as a critical mediator of age-associated diseases, with far-reaching implications for hematologic malignancies, cardiovascular diseases, cancer therapy, autoimmune disorders”

    Review

    Clinical decisions in clonal hematopoiesis: a contemporary review for clinicians

    Haematologica

More on Clonal hematopoiesis of indeterminate potential

Immune response

mediatesin humans1

1 study
  1. Immune response mediates age-related diseases in humans.

    “The immune system plays a central role in the onset of age-related diseases.”

    Review

    Human immune aging

    Immunity

More on Immune response

Senescent cells

upin reviews1

1 study
  1. senescent cells induce age-related diseases.

    “damaged or senescent cells (SnCs) continuously accumulate in the body, altering the local tissue environment and causing various pathologies in different organs or tissues”

    Review

    The drug discovery and therapeutic nano-strategies targeting cellular senescence

    Materials today. Bio

epigenetic regulation of regulated cell death

mediatesin reviews1

1 study
  1. epigenetic regulation of regulated cell death mediates age-related diseases.

    “this epigenetic-RCD axis drives the pathophysiology of major aging-related conditions, such as diabetes, neurodegenerative disorders, cardiovascular diseases, and cancer”

    Review

    Epigenetic Regulation of Regulated Cell Death in Aging-Related Diseases: Clinical Perspectives

    Aging and disease

Epigenetic regulation of gene expression

mediatesin reviews1

1 study
  1. Epigenetic regulation of gene expression mediates age-related diseases.

    “the same epigenetic process that drive development and ageing also underlie age-associated diseases.”

    ReviewTheoretical causal argument under the Evolvable Soma Theory of Ageing, not an empirical causal test

    Evolution, the mother of age-related diseases

    arXiv (Cornell University)Preprint

More on Epigenetic regulation of gene expression

Inflammaging axis

no changein humans1

1 study
  1. Inflammaging axis was not clearly linked with age-related diseases in Tsimane and Orang Asli.

    “no association with age-related diseases”

    Humansin Tsimane and Orang Asli

    Nonuniversality of inflammaging across human populations

    Nature aging

More on Inflammaging axis

Ferroptosis

upin reviews1

1 study
  1. Ferroptosis increases age-related diseases (through decline in cellular defense against ferroptosis during aging).

    “The decline in cellular defence mechanisms against ferroptosis during aging contributes to the accumulation of damaged cells and tissues, ultimately resulting in the manifestation of age-related diseases.”

    Reviewthrough decline in cellular defense against ferroptosis during aging

    Exploring the association between aging, ferroptosis, and common age-related diseases

    Archives of gerontology and geriatrics

More on Ferroptosis

All 30

Associations

216

Cellular senescence

upin reviews26upin humans7no changein reviews2upin silico1+1

37 studies
  1. Cellular senescence raises the risk of age-related diseases.

    “a state of stable cell growth arrest that significantly increases the risk of age-related diseases”

    Review

    Effects of micro- and nano-plastics exposure on cellular senescence: an overview

    Archives of toxicology

  2. Cellular senescence raises the risk of age-related diseases in aging.

    “An increase in senescent cells is common in aging, which leads to age-associated diseases.”

    Reviewin aging

    Neurosenescence, inflammaging and neuroinflammation in neurodegenerative disorders

    Frontiers in aging

  3. Cellular senescence raises the risk of age-related diseases.

    “accumulation of senescent cells has been strongly implicated in the ageing process and the pathogenesis of age-related diseases owing to their pro-inflammatory properties”

    Review

    Functional diversity of senescent cells in driving ageing phenotypes and facilitating tissue regeneration

    Journal of biochemistry

  4. Cellular senescence is associated with age-related diseases.

    “is a key contributor to multiple disorders, diseases and the geriatric syndromes”

    Review

    Targeting senescent cells for the treatment of age-associated diseases

    Journal of biochemistry

  5. Cellular senescence is associated with age-related diseases.

    “the development of age-related diseases is associated with the accumulation of senescent cells in various organs and tissues”

    Review

    Senolytic Vaccines from the Central and Peripheral Tolerance Perspective

    Vaccines

  6. Cellular senescence is associated with age-related diseases.

    “Accumulation of SCs has been linked to onset of several age-related diseases, in the brain, bones, the gastrointestinal tract, and other organs and tissues.”

    Review

    The senotherapeutic potential of phytochemicals for age-related intestinal disease

    Ageing research reviews

  7. Cellular senescence raises the risk of age-related diseases in humans.

    “senescent cells limits both the health of the body and lifespan and even accelerates the occurrence and progression of age-related diseases.”

    Review

    Advances in Nanotherapy for Targeting Senescent Cells

    International journal of nanomedicine

  8. Cellular senescence is associated with age-related diseases in age-related-chronic lung diseases.

    “The role of cellular senescence in age-related diseases has been fully recognized.”

    Reviewin age-related-chronic lung diseases

    Cellular senescence in chronic lung diseases from newborns to the elderly: An update literature review

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

  9. Cellular senescence raises the risk of age-related diseases (continuous accumulation of senescent cells).

    “The continuous accumulation of senescent cells (SnCs) in the body leads to the development of aging and age-related diseases”

    Reviewcontinuous accumulation of senescent cells

    Targeting Cellular Senescence in Aging and Age-Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies

    Aging and disease

  10. Cellular senescence raises the risk of age-related diseases.

    “The involvement of cellular senescence in the initiation and propagation of diseases is clearly characterized”

    Review

    Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment

    npj aging

All 37

More on Cellular senescence

Inflammation

upin humans6upin reviews6upin silico1no changein reviews1

14 studies
  1. Inflammation raises the risk of age-related diseases.

    “Immunosenescence and inflammaging are closely interconnected drivers of age-related disease.”

    Review

    Pharmacological Modulation of Immunosenescence and Inflammaging: Senolytics, Senomorphics, and Emerging Therapies

    Immunological investigations

  2. Inflammation is associated with age-related diseases in silico (hallmarks of aging assessment across aging and ARDs).

    “Hallmarks of aging assessment revealed chronic inflammation as the most enriched hallmark across aging and ARDs.”

    In silicohallmarks of aging assessment across aging and ARDs

    Integrating AI and Causal Genetics to Prioritize Therapeutic Targets for Aging and Age-Related Diseases

    Aging and disease

  3. Inflammation raises the risk of age-related diseases.

    “Chronic inflammation and oxidative stress have been shown to be key drivers of age-related diseases”

    Review

    Telomerase and chronic inflammation as central molecular links in aging

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

  4. Inflammation raises the risk of age-related diseases in humans.

    “chronic, subclinical inflammation occurs, which promotes age-related diseases.”

    Review

    Age-associated changes of the immune system: immunosenescence and effects on vaccinations

    Zeitschrift fur Gerontologie und Geriatrie

  5. Inflammation raises the risk of age-related diseases in aging.

    “Chronic inflammation is one of the key factors driving the development of age-related diseases”

    Reviewin aging

    Pathological and Inflammatory Consequences of Aging

    Biomolecules

  6. Inflammation is associated with age-related diseases (chronic systemic sterile inflammation (inflamm-ageing)).

    “This inflammation is linked to age-related diseases (ARDs), frailty, and increased mortality in older individuals.”

    Reviewchronic systemic sterile inflammation (inflamm-ageing)

    Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies

    International journal of molecular sciences

  7. Inflammation raises the risk of age-related diseases in PLWH on cART.

    “PLWH are predisposed to chronic inflammatory conditions leading to age-associated diseases”

    Reviewin PLWH on cART

    The Many Faces of Immune Activation in HIV-1 Infection: A Multifactorial Interconnection

    Biomedicines

  8. Inflammation is associated with age-related diseases in humans.

    “Depending on which way prevails in an individual, the outcome may be healthy longevity or pathological aging burdened with aging-related diseases.”

    Review

    Immunology of Aging: the Birth of Inflammaging

    Clinical reviews in allergy & immunology

  9. Inflammation is associated with age-related diseases.

    “one specific shared feature seems to be of capital relevance for most of these conditions: the low-grade chronic inflammatory state inherently associated with aging, i.e., inflammaging”

    Review

    The NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process

    Cells

  10. Inflammation raises the risk of age-related diseases in humans.

    “inflammaging is considered the basis of most age-related diseases (ARD).”

    Review

    Human Inflammaging

    Gerontology

All 14

More on Inflammation

Telomere length

mixedin humans3downin humans2upin humans1mixedin reviews1

7 studies
  1. Telomere length is associated with age-related diseases.

    “Despite substantial evidence that links telomere length with these conditions, the nature of these observations remains insufficiently understood.”

    Review

    Telomeres and Age-Related Diseases

    Biomedicines

  2. Telomere length predicts age-related diseases in humans.

    “The short telomere structure detected in both peripheral blood leukocytes and cells of the disease-related tissue has the feature of being a predictive marker for many age-related diseases.”

    Reviewperipheral blood leukocytes and disease-related tissue

    Function of telomere in aging and age related diseases

    Environmental toxicology and pharmacology

  3. Telomere length is associated with age-related diseases in humans.

    “Telomere shortening has been linked to aging and age-related diseases.”

    Review

    Single-molecule telomere length characterization by optical mapping in nano-channel array: Perspective and review on telomere length measurement

    Environmental toxicology and pharmacology

  4. Telomere length is associated with age-related diseases in humans.

    “Telomere length, a complex hereditary trait, is associated with aging and age-related diseases.”

    Review

    Telomeres and Telomere Length: A General Overview

    Cancers

  5. Telomere length is associated with age-related diseases in humans.

    “this system represents among the most salient antecedent cellular phenotypes for common age-related disorders”

    Review

    The fetal programming of telomere biology hypothesis: an update

    Philosophical transactions of the Royal Society of London. Series B, Biological sciences

  6. Telomere length is associated with age-related diseases in humans.

    “epidemiological studies revealing the association of telomere length with age, age-related diseases, and cancers”

    Review

    Integration of Telomere Length Dynamics into Systems Biology Framework: A Review

    Gene regulation and systems biology

  7. Telomere length predicts age-related diseases in humans (inherited telomere syndrome patients and general human cohorts).

    “Greater overall telomere attrition predicts mortality and aging-related diseases in inherited telomere syndrome patients, and also in general human cohorts.”

    Reviewinherited telomere syndrome patients and general human cohorts

    Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection

    Science (New York, N.Y.)

More on Telomere length

Mitochondrial dysfunction

upin reviews5upin humans1

6 studies
  1. mitochondrial dysfunction raises the risk of age-related diseases.

    “mitochondrial dysfunction is a core driver of the aging process and the onset and development of aging-related diseases”

    Review

    Research Progress on the Pathogenic Mechanisms of Mitochondria in Aging-Related Diseases

    Advances in Engineering Technology Research

  2. mitochondrial dysfunction is associated with age-related diseases.

    “mitochondrial dysfunction is a core molecular hallmark and a common pathogenic mechanism underlying multiple age-related disorders”

    Review

    An integrated anti-aging framework targeting NAD⁺ homeostasis, mitochondrial quality control, and redox stability: Roles of NMN/NR, PQQ, and EGT

    Redox biology

  3. mitochondrial dysfunction raises the risk of age-related diseases.

    “mitochondrial dysfunction contributes significantly to the aging process and the development of several age-related diseases”

    Review

    Mitochondria in Aging and Disease: From Cellular Powerhouse to Pathological Trigger

    International Journal of Economic Social Science and Management LAW

  4. Mitochondrial dysfunction is associated with age-related diseases in humans.

    “is linked to the development of numerous age-related pathologies including metabolic syndrome, neurodegenerative disorders, cardiovascular diseases and cancer.”

    Review

    The Mitochondrial Basis of Aging and Age-Related Disorders

    Genes

  5. mitochondrial dysfunction raises the risk of age-related diseases.

    “Mitochondrial dysfunction contributes to normal aging and a wide spectrum of age-related diseases”

    Review

    Mitophagy in neurodegeneration and aging

    Neurochemistry international

  6. mitochondrial dysfunction is associated with age-related diseases.

    “Dysfunction of mitochondria has been associated with ageing and age-related diseases”

    Review

    Mitochondrial activity and dynamics changes regarding metabolism in ageing and obesity

    Mechanisms of ageing and development

Metformin

downin humans5downin reviews1

6 studies
  1. Metformin is associated with age-related diseases in humans.

    “Observational studies suggest associations with reduced incidence of age-related diseases and improved survival”

    Review

    Metformin as a Potential Geroprotective Agent: Mechanisms, Clinical Evidence and Implications for Healthy Aging

    Journal of Education Health and Sport

  2. Metformin lowers the risk of age-related diseases in diabetic and non-diabetic populations.

    “reduces mortality and the incidence of several age-related diseases”

    Reviewin diabetic and non-diabetic populations

    Concept and connotation of the geroprotective and anti-aging effects of metformin: From AMPK activation to SASP suppression

    Molecular and cellular endocrinology

  3. Metformin lowers the risk of age-related diseases.

    “metformin could reduce the risk of age-related diseases including cardiovascular diseases, cancer and neurodegenerative diseases”

    Review

    Metformin and ageing: can treatment delay age-related diseases?

    Nederlands tijdschrift voor geneeskunde

  4. Metformin lowers the risk of age-related diseases in humans (including cardiovascular disease and carcinoma).

    “a number of clinical trials prove positive effects of metformin on the prevalence of age-related diseases (ARD), including cardiovascular disease or carcinoma”

    Reviewincluding cardiovascular disease and carcinoma

    Is metformin a geroprotector? A peek into the current clinical and experimental data

    Mechanisms of ageing and development

  5. Metformin lowers the risk of age-related diseases in humans.

    “metformin can effectively reduce the risk of many age-related diseases and conditions, including cardiometabolic disorders, neurodegeneration, chronic inflammation and frailty”

    Review

    The Use of Metformin to Increase the Human Healthspan

    Advances in experimental medicine and biology

  6. Metformin lowers the risk of age-related diseases in humans.

    “reduces the incidence of aging-related diseases such as neurodegenerative disease and cancer in humans”

    Review

    Metformin as Anti-Aging Therapy: Is It for Everyone?

    Trends in endocrinology and metabolism: TEM

More on Metformin

Oxidative stress and ROS signaling

upin reviews4upin humans1mixedin mice1

6 studies
  1. Oxidative stress and ROS signaling raises the risk of age-related diseases in humans.

    “One of the key contributors to aging and age-related diseases is oxidative stress, resulting from an imbalance between the generation of reactive oxygen species (ROS) and the efficiency of antioxidant defense systems.”

    Review

    The Complexity of Oxidative Stress in Human Age-Related Diseases-A Review

    Metabolites

  2. Oxidative stress and ROS signaling raises the risk of age-related diseases.

    “the vicious cycle between defective mitochondria and mitochondrial oxidative stress contributes to the onset and development of aging and age-related diseases.”

    Review

    Targeting Mitochondrial Oxidative Stress as a Strategy to Treat Aging and Age-Related Diseases

    Antioxidants (Basel, Switzerland)

  3. Oxidative stress and ROS signaling raises the risk of age-related diseases.

    “oxidative stress is a key player in the development and progression of aging and age-associated diseases”

    Review

    Special Issue "Oxidative Stress in Aging and Associated Chronic Diseases"

    Antioxidants (Basel, Switzerland)

  4. Oxidative stress and ROS signaling is associated with age-related diseases.

    “Oxidative stress plays a critical role by inducing structural modifications to biological molecules while affecting their function and catabolism and eventually contributing to the onset of age-related dysfunctions.”

    Review

    Cellular Aging Characteristics and Their Association with Age-Related Disorders

    Antioxidants (Basel, Switzerland)

  5. Age-related diseases are associated with oxidative stress and ROS signaling.

    “diseases associated with the aging process are marked by increased oxidative stress”

    Review

    CoQ10 and Aging

    Biology

  6. Oxidative stress and ROS signaling is associated with age-related diseases in mice (antioxidant mutant mice).

    “incidence of many age-related diseases and pathologies is altered in these models”

    Reviewantioxidant mutant mice

    Revisiting an age-old question regarding oxidative stress

    Free radical biology & medicine

More on Oxidative stress and ROS signaling

Caloric restriction

downin reviews4downin mammals1downin Rodentia1

6 studies
  1. Caloric restriction lowers the risk of age-related diseases.

    “postpone and reduce the incidence of age-related disorders (e.g., type 2 diabetes, cancer and cardiovascular diseases)”

    Review

    The effects and mechanism of caloric restriction on energy metabolism

    Sheng li xue bao : [Acta physiologica Sinica]

  2. Caloric restriction lowers the risk of age-related diseases.

    “In most cases, the lifespan extension is accompanied by a marked delay in the onset of age-associated disease and infirmity.”

    Review

    Hungering for Immortality

    Missouri medicine

  3. Caloric restriction lowers the risk of age-related diseases.

    “delaying the onset of age-related diseases”

    Review

    The use of calorie restriction mimetics to study aging

    Methods in molecular biology (Clifton, N.J.)

  4. Caloric restriction lowers the risk of age-related diseases in mammals.

    “CR has been shown to reduce the incidence of age-related disorders (for example, diabetes, cancer and cardiovascular disorders) in mammals.”

    Review

    Calorie restriction, SIRT1 and metabolism: understanding longevity

    Nature reviews. Molecular cell biology

  5. Caloric restriction lowers the risk of age-related diseases in rodents.

    “It also retards most age-associated physiologic change and age-associated diseases.”

    Reviewin rodents

    Assessment of nutritional components in prolongation of life and health by diet

    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)

  6. Caloric restriction lowers the risk of age-related diseases.

    “Restriction of dietary caloric intake prolongs lifespan and decreases the incidence and severity of diseases associated with aging”

    Review

    Experimental pathology of aging

    Methods and achievements in experimental pathology

More on Caloric restriction

mTOR signaling

upin reviews3mixedin humans1mixedin reviews1

5 studies
  1. mTOR signaling is associated with age-related diseases (persistent activation).

    “Persistent activation of mTOR has been strongly associated with the progression of age-related disorders”

    Reviewpersistent activation

    mTOR signaling in aging and longevity: therapeutic opportunities

    Aging Pathobiology and Therapeutics

  2. mTOR signaling raises the risk of age-related diseases.

    “There is growing evidence that mTOR pathway activity accelerates aging and the development of age-related diseases including cancer, atherosclerosis, diabetes, and declining immune function.”

    Review

    Rapamycin for longevity: the pros, the cons, and future perspectives

    Frontiers in aging

  3. mTOR signaling is associated with age-related diseases in humans (dysregulation of signaling).

    “Dysregulation of mTORC1 signaling is associated with the progression of many types of human disorders including cancer, age-related diseases, neurodegenerative disorders, and metabolic diseases.”

    Reviewdysregulation of signaling

    Nutrient sensing of mTORC1 signaling in cancer and aging

    Seminars in cancer biology

  4. mTOR signaling is associated with age-related diseases.

    “mTOR dysregulation is involved in several age-related diseases, such as cancer, neurodegenerative diseases, and type 2 diabetes mellitus”

    Review

    The role of mTOR in age-related diseases

    Journal of enzyme inhibition and medicinal chemistry

  5. mTOR signaling is associated with age-related diseases (mTOR pathway deregulation).

    “Deregulation of the mTOR signalling pathway is implicated in multiple age-related diseases such as cancer, neurodegeneration, and auto-immunity”

    ReviewmTOR pathway deregulation

    The Target of Rapamycin Signalling Pathway in Ageing and Lifespan Regulation

    Genes

More on mTOR signaling

Senescence-associated secretory phenotype (SASP)

upin reviews4upin humans1

5 studies
  1. Senescence-associated secretory phenotype (SASP) is associated with age-related diseases.

    “Senescence and SASP are implicated in numerous age-related diseases.”

    Review

    The role of the dynamic epigenetic landscape in senescence: orchestrating SASP expression

    npj aging

  2. Senescence-associated secretory phenotype (SASP) raises the risk of age-related diseases.

    “SASP (senescence-associated secretory phenotype) that impairs tissue homeostasis and is involved in numerous age-related diseases.”

    Review

    Lipid remodeling in context of cellular senescence

    Biochimie

  3. Senescence-associated secretory phenotype (SASP) raises the risk of age-related diseases.

    “SASP aids in the emergence of several age-related diseases.”

    Review

    Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications

    Current topics in medicinal chemistry

  4. Senescence-associated secretory phenotype (SASP) raises the risk of age-related diseases in humans.

    “development of senescence-associated secretory phenotype (SASP), whose pro-inflammatory components affect tissues and organs, and increases the possibility of age-related diseases”

    Review

    Aging of Liver in Its Different Diseases

    International journal of molecular sciences

  5. Senescence-associated secretory phenotype (SASP) raises the risk of age-related diseases.

    “the redox-regulated signaling networks controlling the SASP and its important role in driving age-related diseases.”

    Review

    Redox control of senescence and age-related disease

    Redox biology

More on Senescence-associated secretory phenotype (SASP)

Immunosenescence

upin reviews3

3 studies
  1. immunosenescence raises the risk of age-related diseases.

    “Immunosenescence contributes to the pathogenesis of diverse age-related diseases.”

    Review

    Immunosenescence in Human Disease: Mechanistic Insights and Therapeutic Opportunities

    Biomolecules & therapeutics

  2. Immunosenescence is associated with age-related diseases.

    “immunosenescence, which had great effects on the occurrence and development of age-related diseases.”

    Review

    Immunosenescence, aging and successful aging

    Frontiers in immunology

  3. immunosenescence raises the risk of age-related diseases.

    “The immune system deteriorates during ageing and contributes to many of these age-associated diseases”

    Review

    Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells

    Aging cell

All 216

Funding

133 grants since 2016

National Institute on Aging$65.8MJapan Society for the Promotion of Science¥575MNational Institute of Environmental Health Sciences$25.7M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies associate age-related diseases with social disadvantage and biological-age measures; a preprint reports prediction by a plasma protein panel. Late-life clearance of p16INK4A-positive senescent cells reduces age-related disease in BubR1 progeroid mice. Reviews link telomere shortening to disease, while a preprint finds no telomere-length association with multimorbidity in Hong Kong’s Chinese oldest old.

  2. Summary rewritten as its findings changed.

    As it read before

    Human studies link age-related diseases to global disease burden and report lower risk with the Myth diet. A human preprint associates MetScore2 with age-related diseases; a review links gut–liver axis disruption to increased risk.

  3. Summary written from the findings.

Latest

Research Square

Blood protein scores linked to future age-related disease

In 44,526 UK Biobank participants, 10-year disease incidence differed up to 20-fold between people of the same age with different scores.In 44,526 UK Biobank participants, 10-year disease incidence differed up to 20-fold between people of the same age with different scores.

Preprint: cohort · 44,526 peopleBiomarkers
Research Square

Age, HIV and illness linked to altered immune-cell responses

An observational study of 147 people linked age, HIV and coexisting illnesses to higher resting inflammatory activity and weaker immune-cell responses to microbial…An observational study of 147 people linked age, HIV and coexisting illnesses to higher resting inflammatory activity and weaker immune-cell responses to microbial signals.

Preprint: cross-sectional · 147 peopleBlood and immune system

See all 5,770 papers on age-related diseases